669 related articles for article (PubMed ID: 30830381)
1. Investigation of altered urinary metabolomic profiles of invasive ductal carcinoma of breast using targeted and untargeted approaches.
More TH; Taware R; Taunk K; Chanukuppa V; Naik V; Mane A; Rapole S
Metabolomics; 2018 Aug; 14(8):107. PubMed ID: 30830381
[TBL] [Abstract][Full Text] [Related]
2. Metabolomic study of serum in patients with invasive ductal breast carcinoma with LC-MS/MS approach.
Amiri-Dashatan N; Yekta RF; Koushki M; Arefi Oskouie A; Esfahani H; Taheri S; Kazemian E
Int J Biol Markers; 2022 Dec; 37(4):349-359. PubMed ID: 36168301
[TBL] [Abstract][Full Text] [Related]
3. Metabolomic alterations in invasive ductal carcinoma of breast: A comprehensive metabolomic study using tissue and serum samples.
More TH; RoyChoudhury S; Christie J; Taunk K; Mane A; Santra MK; Chaudhury K; Rapole S
Oncotarget; 2018 Jan; 9(2):2678-2696. PubMed ID: 29416801
[TBL] [Abstract][Full Text] [Related]
4. The combination of four analytical methods to explore skeletal muscle metabolomics: Better coverage of metabolic pathways or a marketing argument?
Bruno C; Patin F; Bocca C; Nadal-Desbarats L; Bonnier F; Reynier P; Emond P; Vourc'h P; Joseph-Delafont K; Corcia P; Andres CR; Blasco H
J Pharm Biomed Anal; 2018 Jan; 148():273-279. PubMed ID: 29059617
[TBL] [Abstract][Full Text] [Related]
5. Integrated metabolomic profiling of hepatocellular carcinoma in hepatitis C cirrhosis through GC/MS and UPLC/MS-MS.
Fitian AI; Nelson DR; Liu C; Xu Y; Ararat M; Cabrera R
Liver Int; 2014 Oct; 34(9):1428-44. PubMed ID: 24661807
[TBL] [Abstract][Full Text] [Related]
6. Metabolic signatures of osteoarthritis in urine using liquid chromatography-high resolution tandem mass spectrometry.
Abdelrazig S; Ortori CA; Doherty M; Valdes AM; Chapman V; Barrett DA
Metabolomics; 2021 Mar; 17(3):29. PubMed ID: 33655418
[TBL] [Abstract][Full Text] [Related]
7. LC-MS untargeted metabolomics assesses the delayed response of glufosinate treatment of transgenic glufosinate resistant (GR) buffalo grasses (Stenotaphrum secundatum L.).
Boonchaisri S; Rochfort S; Stevenson T; Dias DA
Metabolomics; 2021 Feb; 17(3):28. PubMed ID: 33609206
[TBL] [Abstract][Full Text] [Related]
8. Metabolic profiling of potential lung cancer biomarkers using bronchoalveolar lavage fluid and the integrated direct infusion/ gas chromatography mass spectrometry platform.
Callejón-Leblic B; García-Barrera T; Grávalos-Guzmán J; Pereira-Vega A; Gómez-Ariza JL
J Proteomics; 2016 Aug; 145():197-206. PubMed ID: 27255828
[TBL] [Abstract][Full Text] [Related]
9. Metabolomic Analysis Using Liquid Chromatography/Mass Spectrometry for Gastric Cancer.
Liang Q; Wang C; Li B
Appl Biochem Biotechnol; 2015 Aug; 176(8):2170-84. PubMed ID: 26088916
[TBL] [Abstract][Full Text] [Related]
10. Metabolomics of papillary thyroid carcinoma tissues: potential biomarkers for diagnosis and promising targets for therapy.
Shang X; Zhong X; Tian X
Tumour Biol; 2016 Aug; 37(8):11163-75. PubMed ID: 26935059
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer detection using targeted plasma metabolomics.
Jasbi P; Wang D; Cheng SL; Fei Q; Cui JY; Liu L; Wei Y; Raftery D; Gu H
J Chromatogr B Analyt Technol Biomed Life Sci; 2019 Jan; 1105():26-37. PubMed ID: 30562627
[TBL] [Abstract][Full Text] [Related]
12. Serum metabolomic alterations in multiple myeloma revealed by targeted and untargeted metabolomics approaches: a pilot study.
Chanukuppa V; More TH; Taunk K; Taware R; Chatterjee T; Sharma S; Rapole S
RSC Adv; 2019 Sep; 9(51):29522-29532. PubMed ID: 35531512
[TBL] [Abstract][Full Text] [Related]
13. Urinary metabolite and lipid alterations in Colombian Hispanic women with breast cancer: A pilot study.
Cala M; Aldana J; Sánchez J; Guio J; Meesters RJW
J Pharm Biomed Anal; 2018 Apr; 152():234-241. PubMed ID: 29428809
[TBL] [Abstract][Full Text] [Related]
14. Urinary Metabolomics Identified Metabolic Perturbations Associated with Gutka, a Smokeless Form of Tobacco.
Jorvekar SB; Jala A; Rai A; Jangili S; Adla D; Borkar G; Das A; Kakati K; Das K; Sarma A; Mutheneni SR; Borkar RM
Chem Res Toxicol; 2023 Apr; 36(4):669-684. PubMed ID: 36976269
[TBL] [Abstract][Full Text] [Related]
15. Urease-immobilized magnetic microparticles in urine sample preparation for metabolomic analysis by gas chromatography-mass spectrometry.
Jáčová J; Jořenek M; Pospíšková K; Najdekr L; Zajoncová L; Friedecký D; Adam T
J Chromatogr A; 2019 Nov; 1605():360355. PubMed ID: 31315811
[TBL] [Abstract][Full Text] [Related]
16. Coccidioidomycosis Detection Using Targeted Plasma and Urine Metabolic Profiling.
Jasbi P; Mitchell NM; Shi X; Grys TE; Wei Y; Liu L; Lake DF; Gu H
J Proteome Res; 2019 Jul; 18(7):2791-2802. PubMed ID: 31244214
[TBL] [Abstract][Full Text] [Related]
17. Distinct pattern of one-carbon metabolism, a nutrient-sensitive pathway, in invasive breast cancer: A metabolomic study.
Santos JR; Waitzberg DL; da Silva IDCG; Junior TCT; Barros LRC; Canuto GAB; Faccio AT; Yamaguchi LF; Kato MJ; Tavares MFM; Martinez AC; Logullo ÂF; Torrinhas RSMM; Ravacci G
Oncotarget; 2020 May; 11(18):1637-1652. PubMed ID: 32405339
[TBL] [Abstract][Full Text] [Related]
18. Proteomic Analysis of Urine to Identify Breast Cancer Biomarker Candidates Using a Label-Free LC-MS/MS Approach.
Beretov J; Wasinger VC; Millar EK; Schwartz P; Graham PH; Li Y
PLoS One; 2015; 10(11):e0141876. PubMed ID: 26544852
[TBL] [Abstract][Full Text] [Related]
19. Early Breast Cancer Detection Using Untargeted and Targeted Metabolomics.
Wei Y; Jasbi P; Shi X; Turner C; Hrovat J; Liu L; Rabena Y; Porter P; Gu H
J Proteome Res; 2021 Jun; 20(6):3124-3133. PubMed ID: 34033488
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
